Annual EBITDA
-$180.93 M
-$10.45 M-6.13%
31 December 2023
Summary:
AlloVir annual earnings before interest, taxes, depreciation & amortization is currently -$180.93 million, with the most recent change of -$10.45 million (-6.13%) on 31 December 2023. During the last 3 years, it has fallen by -$109.70 million (-153.99%). ALVR annual EBITDA is now -4931.51% below its all-time high of -$3.60 million, reached on 31 December 2018.ALVR EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$5.64 M
+$1.63 M+22.38%
30 September 2024
Summary:
AlloVir quarterly earnings before interest, taxes, depreciation & amortization is currently -$5.64 million, with the most recent change of +$1.63 million (+22.38%) on 30 September 2024. Over the past year, it has increased by +$41.24 million (+87.97%). ALVR quarterly EBITDA is now -103.28% below its all-time high of -$2.77 million, reached on 31 March 2019.ALVR Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$79.43 M
+$41.24 M+34.18%
30 September 2024
Summary:
AlloVir TTM earnings before interest, taxes, depreciation & amortization is currently -$79.43 million, with the most recent change of +$41.24 million (+34.18%) on 30 September 2024. Over the past year, it has increased by +$98.16 million (+55.27%). ALVR TTM EBITDA is now -2764.37% below its all-time high of -$2.77 million, reached on 31 March 2019.ALVR TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ALVR EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -6.1% | +88.0% | +55.3% |
| 3 y3 years | -154.0% | +87.6% | +43.0% |
| 5 y5 years | -4931.5% | +33.5% | -361.9% |
ALVR EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -154.0% | at low | at high | +89.9% | at high | +57.9% |
| 5 y | 5 years | -4931.5% | at low | at high | +89.9% | -361.9% | +57.9% |
| alltime | all time | -4931.5% | at low | -103.3% | +89.9% | -2764.4% | +57.9% |
AlloVir EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$5.64 M(-22.4%) | -$79.43 M(-34.2%) |
| June 2024 | - | -$7.26 M(-68.2%) | -$120.67 M(-24.9%) |
| Mar 2024 | - | -$22.84 M(-47.7%) | -$160.62 M(-11.2%) |
| Dec 2023 | -$180.93 M(+6.1%) | -$43.70 M(-6.8%) | -$180.93 M(+1.9%) |
| Sept 2023 | - | -$46.88 M(-0.7%) | -$177.59 M(+2.3%) |
| June 2023 | - | -$47.22 M(+9.4%) | -$173.58 M(+1.6%) |
| Mar 2023 | - | -$43.15 M(+6.9%) | -$170.90 M(+0.2%) |
| Dec 2022 | -$170.48 M(+0.5%) | -$40.35 M(-5.9%) | -$170.48 M(-8.3%) |
| Sept 2022 | - | -$42.87 M(-3.8%) | -$185.83 M(-1.4%) |
| June 2022 | - | -$44.54 M(+4.2%) | -$188.43 M(+3.8%) |
| Mar 2022 | - | -$42.73 M(-23.3%) | -$181.51 M(+7.0%) |
| Dec 2021 | -$169.63 M | -$55.70 M(+22.5%) | -$169.63 M(+21.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2021 | - | -$45.46 M(+20.8%) | -$139.32 M(+18.3%) |
| June 2021 | - | -$37.62 M(+22.0%) | -$117.75 M(+27.6%) |
| Mar 2021 | - | -$30.84 M(+21.4%) | -$92.26 M(+29.5%) |
| Dec 2020 | -$71.24 M(+167.0%) | -$25.40 M(+6.3%) | -$71.24 M(+28.8%) |
| Sept 2020 | - | -$23.88 M(+96.8%) | -$55.32 M(+38.6%) |
| June 2020 | - | -$12.13 M(+23.5%) | -$39.92 M(+18.3%) |
| Mar 2020 | - | -$9.82 M(+3.5%) | -$33.73 M(+26.4%) |
| Dec 2019 | -$26.68 M(+642.0%) | -$9.49 M(+11.9%) | -$26.68 M(+55.2%) |
| Sept 2019 | - | -$8.48 M(+42.6%) | -$17.20 M(+97.2%) |
| June 2019 | - | -$5.95 M(+114.4%) | -$8.72 M(+214.4%) |
| Mar 2019 | - | -$2.77 M | -$2.77 M |
| Dec 2018 | -$3.60 M | - | - |
FAQ
- What is AlloVir annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for AlloVir?
- What is AlloVir annual EBITDA year-on-year change?
- What is AlloVir quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for AlloVir?
- What is AlloVir quarterly EBITDA year-on-year change?
- What is AlloVir TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for AlloVir?
- What is AlloVir TTM EBITDA year-on-year change?
What is AlloVir annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of ALVR is -$180.93 M
What is the all time high annual EBITDA for AlloVir?
AlloVir all-time high annual earnings before interest, taxes, depreciation & amortization is -$3.60 M
What is AlloVir annual EBITDA year-on-year change?
Over the past year, ALVR annual earnings before interest, taxes, depreciation & amortization has changed by -$10.45 M (-6.13%)
What is AlloVir quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of ALVR is -$5.64 M
What is the all time high quarterly EBITDA for AlloVir?
AlloVir all-time high quarterly earnings before interest, taxes, depreciation & amortization is -$2.77 M
What is AlloVir quarterly EBITDA year-on-year change?
Over the past year, ALVR quarterly earnings before interest, taxes, depreciation & amortization has changed by +$41.24 M (+87.97%)
What is AlloVir TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of ALVR is -$79.43 M
What is the all time high TTM EBITDA for AlloVir?
AlloVir all-time high TTM earnings before interest, taxes, depreciation & amortization is -$2.77 M
What is AlloVir TTM EBITDA year-on-year change?
Over the past year, ALVR TTM earnings before interest, taxes, depreciation & amortization has changed by +$98.16 M (+55.27%)